We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-2.45%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.1B
AUM Growth
-$4.47B
Cap. Flow
-$3.98B
Cap. Flow %
-39.35%
Top 10 Hldgs %
25.88%
Holding
2,114
New
677
Increased
359
Reduced
350
Closed
725

Top Buys

Rank Stock Value
1
AEE icon
Ameren
AEE
+$161M
2
ETR icon
Entergy
ETR
+$126M
3
DHR icon
Danaher
DHR
+$124M
4
COO icon
Cooper Companies
COO
+$65.6M
5
PPL
PPL Corp
PPL
+$61.3M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$419M
2
CMS icon
CMS Energy
CMS
+$170M
3
DUK icon
Duke Energy
DUK
+$164M
4
C icon
Citigroup
C
+$124M
5
CVX icon
Chevron
CVX
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 13.02%
2 Utilities 9.78%
3 Financials 9.29%
4 Technology 8.37%
5 Consumer Discretionary 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEEL
1476
Keel Infrastructure Corp
KEEL
$2.05B
-79,000
Closed -$118K
BKH icon
1477
Black Hills Corp
BKH
$5.47B
-67,427
Closed -$3.95M
BKNG icon
1478
CALL
Booking.com
BKNG
$158B
-5,000
Closed -$1.02M
BKNG icon
1479
Booking.com
BKNG
$158B
-3,250
Closed -$646K
BKNG icon
1480
PUT
Booking.com
BKNG
$158B
-5,000
Closed -$1.02M
BKR icon
1481
Baker Hughes
BKR
$61.9B
-415,576
Closed -$17M
BKSY icon
1482
BlackSky Technology
BKSY
$1.14B
-65,114
Closed -$703K
BLBD icon
1483
Blue Bird Corp
BLBD
$1.96B
-76,300
Closed -$2.95M
BLCO icon
1484
Bausch + Lomb
BLCO
$6.16B
-366,721
Closed -$6.62M
BLFS icon
1485
BioLife Solutions
BLFS
$1.81B
-26,662
Closed -$692K
BLZE icon
1486
Backblaze
BLZE
$978M
-54,719
Closed -$329K
BMRN icon
1487
BioMarin Pharmaceuticals
BMRN
$12.9B
-49,817
Closed -$3.27M
BMY icon
1488
Bristol-Myers Squibb
BMY
$137B
-342,315
Closed -$19.4M
BPMC
1489
DELISTED
Blueprint Medicines
BPMC
-2,512
Closed -$219K
BR icon
1490
Broadridge
BR
$20.8B
-19,479
Closed -$4.4M
BRBR icon
1491
BellRing Brands
BRBR
$1.18B
-53,380
Closed -$4.02M
BRC icon
1492
Brady Corp
BRC
$4.3B
-59,200
Closed -$4.37M
BRO icon
1493
Brown & Brown
BRO
$24.4B
-88,687
Closed -$9.05M
BRX icon
1494
Brixmor Property Group
BRX
$8.99B
-728,129
Closed -$20.3M
BTU icon
1495
Peabody Energy
BTU
$3.37B
-409,039
Closed -$8.56M
BUD icon
1496
AB InBev
BUD
$155B
-47,091
Closed -$2.36M
BURL icon
1497
Burlington
BURL
$20.6B
-14,102
Closed -$4.02M
BUSE icon
1498
First Busey Corp
BUSE
$2.5B
-120,251
Closed -$2.83M
BV icon
1499
BrightView Holdings
BV
$1.05B
-264,964
Closed -$4.24M
BX icon
1500
PUT
Blackstone
BX
$108B
-2,500
Closed -$431K

Similar funds

Michael Gelband's Q1 2025 Portfolio in Review

As of Q1 2025, Michael Gelband held 2,114 positions worth $10.1B, down 31% from $14.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.98B in Q1 2025, closing 725 positions and reducing 350 holdings. Its most notable exit was CMS Energy, an estimated $170M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8% a quarter earlier, followed by Utilities and Financials.

Against the trend, Michael Gelband opened a new position in Ameren worth $168M.

  • Michael Gelband's largest Q1 2025 buy was Ameren: 1,668,398 shares worth $168M.
  • Michael Gelband added most to Danaher in Q1 2025, an estimated $124M increase.
  • Michael Gelband's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $419M.
  • Michael Gelband fully exited CMS Energy in Q1 2025, selling an estimated $170M.
  • Michael Gelband's ten largest holdings make up 26% of its $10.1B portfolio in Q1 2025.
  • Michael Gelband opened 677 new positions and closed 725 in Q1 2025.
  • Michael Gelband's portfolio value fell 31% quarter-over-quarter to $10.1B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.